WO2001075057A3 - A novel polypeptide, human ribosomal s4 protein 12 and the polynucleotide encoding the polypeptide - Google Patents
A novel polypeptide, human ribosomal s4 protein 12 and the polynucleotide encoding the polypeptide Download PDFInfo
- Publication number
- WO2001075057A3 WO2001075057A3 PCT/CN2001/000524 CN0100524W WO0175057A3 WO 2001075057 A3 WO2001075057 A3 WO 2001075057A3 CN 0100524 W CN0100524 W CN 0100524W WO 0175057 A3 WO0175057 A3 WO 0175057A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptide
- protein
- polynucleotide encoding
- human ribosomal
- discloses
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 102000040430 polynucleotide Human genes 0.000 title abstract 3
- 108091033319 polynucleotide Proteins 0.000 title abstract 3
- 239000002157 polynucleotide Substances 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 210000003705 ribosome Anatomy 0.000 title abstract 3
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention discloses a novel polypeptide, a human ribosomal S4 protein 12, the polynucleotide encoding the polypeptide and the method for producing the polypeptide by DNA recombinant technology. The invention also discloses the uses of the polypeptide in methods for treating various diseases, such as malignant tumor, hemopathy, HIV infection, immunological disease, and various inflammation, etc. The invention also discloses the agonists against the polypeptide and the therapeutic action thereof. The invention also discloses the uses of the polynucleotide encoding the human ribosomal S4 protein 12.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU73779/01A AU7377901A (en) | 2000-03-29 | 2001-03-26 | A novel polypeptide, human ribosomal s4 protein 12 and the polynucleotide encoding the polypeptide |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00115295.3 | 2000-03-29 | ||
| CN00115295A CN1315455A (en) | 2000-03-29 | 2000-03-29 | Polypeptide-human S4 ribosome protein 12 and polynucleotide for coding it |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2001075057A2 WO2001075057A2 (en) | 2001-10-11 |
| WO2001075057A3 true WO2001075057A3 (en) | 2002-01-24 |
Family
ID=4584763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2001/000524 WO2001075057A2 (en) | 2000-03-29 | 2001-03-26 | A novel polypeptide, human ribosomal s4 protein 12 and the polynucleotide encoding the polypeptide |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1315455A (en) |
| AU (1) | AU7377901A (en) |
| WO (1) | WO2001075057A2 (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4865970A (en) * | 1986-02-28 | 1989-09-12 | Hoffmann-La Roche Inc. | Method of detecting ribosomal protein antibodies in systemic lupus erythematosus |
| WO2000028079A2 (en) * | 1998-11-09 | 2000-05-18 | Gemini Genomics Ab | Genetic variation associated with aplastic anemia, and diagnosis and therapy based thereon |
-
2000
- 2000-03-29 CN CN00115295A patent/CN1315455A/en active Pending
-
2001
- 2001-03-26 WO PCT/CN2001/000524 patent/WO2001075057A2/en active Application Filing
- 2001-03-26 AU AU73779/01A patent/AU7377901A/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4865970A (en) * | 1986-02-28 | 1989-09-12 | Hoffmann-La Roche Inc. | Method of detecting ribosomal protein antibodies in systemic lupus erythematosus |
| WO2000028079A2 (en) * | 1998-11-09 | 2000-05-18 | Gemini Genomics Ab | Genetic variation associated with aplastic anemia, and diagnosis and therapy based thereon |
Non-Patent Citations (3)
| Title |
|---|
| DATABASE GENBANK [online] 23 November 1999 (1999-11-23), LAWLOR S.: "Human DNA sequence from clone 170F5 on chromosome Xq22.3-24. Contains an HMG1 (high-mobility group (nonhitone chromosomal) protein 1) pseudogene and ESTs, STSs and GSSs", retrieved from HS170F5 Database accession no. AL035067.2 * |
| DECKERT G. ET AL.: "The complete genome of the hyperthermophilic bacterium aquifex aeolicus", NATURE, vol. 392, no. 6674, 1998, pages 353 - 358 * |
| IVENS A.C. ET AL.: "A physical map of the leischmania major friedlin genome", GENOME RESEARCH, vol. 8, no. 2, 1998, pages 135 - 145 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001075057A2 (en) | 2001-10-11 |
| AU7377901A (en) | 2001-10-15 |
| CN1315455A (en) | 2001-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001075048A3 (en) | A novel polypeptide, human ribosomal protein s11 23 and the polynucleotide encoding the polypeptide | |
| WO2001075036A3 (en) | A novel polypeptide, human immunophiline 14 and the polynucleotide encoding the polypeptide | |
| WO2001075057A3 (en) | A novel polypeptide, human ribosomal s4 protein 12 and the polynucleotide encoding the polypeptide | |
| WO2001075016A3 (en) | A novel polypeptide, a human tyrosinase 16, and the polynucleotide encoding the polypeptide | |
| WO2002000821A3 (en) | A novel polypeptide, a human protein plp39 and the polynucleotide encoding the polypeptide | |
| WO2001075011A3 (en) | A novel polypeptide, cytochrome human constitution protein 10 and the polynucleotide encoding the polypeptide | |
| WO2001075028A3 (en) | A novel polypeptide, human ribosomal protein s4-12 and the polynucleotide encoding the polypeptide | |
| WO2002000828A3 (en) | A novel polypeptide, a zinc-finger protein 34 and the polynucleotide encoding the polypeptide | |
| WO2001079431A3 (en) | A novel polypeptide, a human pathway 15 protein with the huntingtine protein and the polynucleotide encoding the polypeptide | |
| WO2001083682A3 (en) | A novel polypeptide, a human pax protein 11.6 and the polynucleotide encoding the polypeptide | |
| WO2001094532A3 (en) | A novel polypeptide, ribosomal protein l39 9 and the polynucleotide encoding the polypeptide | |
| WO2001075034A3 (en) | A novel polypeptide, human peroxydase protein 15 and the polynucleotide encoding the polypeptide | |
| WO2001075035A3 (en) | A novel polypeptide, human peroxydase protein 9 and the polynucleotide encoding the polypeptide | |
| WO2001083687A3 (en) | A novel polypeptide, a human pax protein 23 and the polynucleotide encoding the polypeptide | |
| WO2001083681A3 (en) | A novel polypeptide, a human dihydroorotase 21 and the polynucleotide encoding the polypeptide | |
| WO2001075056A3 (en) | A novel polypeptide, human light-chain clathrine 20 and the polynucleotide encoding the polypeptide | |
| WO2001064866A1 (en) | A novel polypeptide, a ribosome s19e protein 11 and the polynucleotide encoding the polypeptide | |
| WO2001075039A3 (en) | A novel polypeptide, human rna helicase 10 and the polynucleotide encoding the polypeptide | |
| WO2001075024A3 (en) | A novel polypeptide, nf-e2-associated human factor 13 and the polynucleotide encoding the polypeptide | |
| WO2001075058A3 (en) | A NOVEL POLYPEPTIDE, HUMAN AMINOACYL-tRNA SYNTHETASE 15 TYPE II AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE | |
| WO2001077287A3 (en) | A novel polypeptide, human uterine globine 11 and the polynucleotide encoding the polypeptide | |
| WO2001075043A3 (en) | A novel polypeptide, dna-dependent human protein kinase 9 and the polynucleotide encoding the polypeptide | |
| WO2001075003A3 (en) | A NOVEL POLYPEPTIDE, A HUMAN UTERUS PROTEIN ASSOCIATED WITH A cpn 60 26 MOLECULE AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE | |
| WO2001075002A3 (en) | A novel polypeptide, cellular cycle regulation gene 28 and the polynucleotide encoding the polypeptide | |
| WO2001075053A3 (en) | A novel polypeptide, human chaperonine 14 and the polynucleotide encoding the polypeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |